spacer
home > ict > winter 2019 > the evolution of environmental monitoring
PUBLICATIONS
International Clinical Trials

The Evolution of Environmental Monitoring

Clinical trials are a complex undertaking and a huge investment for the sponsor, taking a significant amount of time to complete and to produce a marketable drug. Added complexity comes from the inherently global nature of recent clinical trials which are spreading operations over multiple nations, sites, and premises. Ensuring sufficient enrolment numbers and monitoring activities on multiple sites and suchlike justifiably take up a major portion of sponsor and investigator focus.

A Complicated Process

With the vast amount of analytical activities in a clinical study, it is easy to forget that even in national – and more so, in international studies – logistics complexity is a major concern. However, while logistics is a support function for the overall trial operation, it also needs planning to function efficiently.

In a drug trial, ensuring that the investigational medicinal products (IMPs) reach the site in good condition and that samples travel from collection points to laboratories in correct environments is paramount. With lab specialisation requiring long transportation distances and the parallel supply chains of international, regional, and local hubs often working without visibility to each other, guaranteeing the integrity of the supply is not always easy.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Jukkapekka ‘JP’ Asikainen is the founder and CEO at Sensire. He is a leading expert on the cold supply chain and an accomplished innovator of marketleading wireless monitoring solutions for pharma logistics, healthcare services, and processing and manufacturing operations. JP is a highly successful serial entrepreneur and has over 30 years’ experience in executive management, marketing and sales. As a longtime specialist on environmental monitoring systems, JP is exceedingly experienced at providing customers with real-life solutions to real-world challenges.

Ossi Laakkonen is Technical Director at Sensire. He is an expert in cold supply chain technology design and accomplished in designing robust and comprehensive environmental monitoring systems for a wide variety of applications. Ossi’s speciality is in the field of IoT and he has over 10 years of experience with working on wireless sensor network research and development. He also holds several groundbreaking patents on these technologies.
spacer
Jukkapekka ‘JP’ Asikainen
spacer
spacer
spacer
Ossi Laakkonen
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Janssen Announces Phase 1 Results for Bispecific Antibody Amivantamab in the Treatment of Patients with Advanced Non-Small Cell Lung Cancer Harbouring Exon 20 Insertion Mutations

The Janssen Pharmaceutical Companies of Johnson & Johnson today announced results from the Phase 1 CHRYSALIS study evaluating amivantamab (JNJ-6372) in the treatment of patients with advanced non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) Exon 20 insertion mutations. Amivantamab is an EGFR and MET-targeted bispecific antibody, which targets activating and resistance EGFR mutations, and MET pathway activation.
More info >>

White Papers

R&D to Product: How to Reduce Costly Scale-Up Problems

Natoli Engineering Company, Inc.

When scaling a new drug formulation from the development side of R&D into manufacturing, there is often a reality check with respect to process scaleup and performance of the formulation at production levels. Problems with capping/lamination and sticking/ picking are often first realized when a formulation is introduced to a level of compression required to supply market demand.
More info >>

 
Industry Events

World Vaccine Congress Europe

18-21 October 2020, Barcelona, Spain

The World Vaccine Congress is an award-winning series of conferences and exhibitions that have grown to become the largest and most established vaccine meeting of its kind across the globe. Our credibility is show through the prestigious scientific advisory board that spend months of hard work creating a new and topical agenda, year on year.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement